Veeva Systems surges after Q2 earnings beat estimates

Shares of healthcare tech firm Veeva Systems (VEEV.N) gain more than 7% to $264.19 in premarket trading.

The company posts Q2 revenue of $927.96 million versus estimates of $905.28 million; adjusted EPS is $2.35, above estimates of $2.22.

Twenty-one out of 30 brokerages rate the stock "buy" or higher, eight "hold" and one "sell"; their median price target is $295 — LSEG data.

Up to the last day's close, the stock is up 9.7% year to date.